Jed Latkin | Chief Executive Officer, Chief Financial Officer and Chief Operating Officer |
Michael Rosol | Chief Medical Officer |
Erika Gibson | Director, Finance and Administration |
Jason McCarthy | Maxim Group |
Greetings, and welcome to the Navidea Biopharmaceuticals’ Q2 2019 Earnings Conference Call. At this time, all participants are in a listen-only-mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Jed Latkin, CEO.